Making comprehensive genomic profiling available to patients around the world
Roche and Foundation Medicine® Collaboration
Roche is making Foundation Medicine's comprehensive genomic profiling services available to patients outside of the United States.
As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation, and experience in cancer profiling, together we’re:1
- Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
- Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials
Need More Details?
Our dedicated client service team offers assistance throughout the process and our medical team is available to support you with interpretation of the report on request.